Wall Street’s major averages ended slightly lower last week, after posting back-to-back record closes as market participants juggled Trump's tariff announcements against a healthy appetite for ...

Cambridge: Moderna has received approval from the U.S. Food and Drug Administration (FDA) for the supplemental Biologics ...

Moderna reports it has received full approval from the U.S. Food and Drug Administration for its COVID-19 vaccine, Spikevax, in children six months through 11 years of age, who are at an increased ...